Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 1;47(6):820-822.
doi: 10.1097/DSS.0000000000002739.

Complete and Sustained Remission of Metastatic Cutaneous Squamous Cell Carcinoma in a Liver Transplant Patient Treated With Talimogene Laherparepvec

Tuyet A Nguyen  1 , Michelle Offner  2 , Omid Hamid  2 , Zachary S Zumsteg  3 , Nima M Gharavi  4
Affiliations
Case Reports

Complete and Sustained Remission of Metastatic Cutaneous Squamous Cell Carcinoma in a Liver Transplant Patient Treated With Talimogene Laherparepvec

Tuyet A Nguyen et al. Dermatol Surg. .
No abstract available

PubMed Disclaimer

References

    1. Bibee K, Swartz A, Sridharan S, Kurten CHL, et al. Cutaneous squamous cell carcinoma in the organ transplant recipient. Oral Oncol 2020;103:104562.
    1. Manyam BV, Garsa AA, Chin RI, Reddy CA, et al. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer 2017;123:2054–60.
    1. Fisher J, Zeitouni N, Fan W, Samie FH. Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review. J Am Acad Dermatol 2020;82:1490–500.
    1. Ressler J, Silmbrod R, Stepan A, Tuchmann F, et al. Talimogene laherparepvec (T-VEC) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report. Br J Dermatol 2019;181:186–9.
    1. Harrington KJ, Hingorani M, Tanay MA, Hickey J, et al. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck. Clin Cancer Res 2010;16:4005–15.

Publication types

MeSH terms

Substances

LinkOut - more resources